VIVO explains how ddPCR and NGS support viral surveillance in antiviral trials, from detection and quantification to ...
NJEN Bio announced on July 21 that it has signed a channel partner agreement with the global genomics analysis company Illumina for the distribution o ...
Guardant Health has delivered exceptional growth, with revenue up 48% YoY and its Shield screening segment surging 633% YoY.
For 13 days, excavation teams worked through a single trench beneath Le Thi Rieng Park, carefully uncovering the remains of ...
More than half a century after the war ended, Vietnam is still searching for around 175,000 fallen soldiers whose remains ...
Vietnam is moving to accelerate the use of next-generation DNA technology to identify the remains of fallen soldiers, ...
Microbiome sequencing has a reputation issue. From the outside, it appears to be one of modern biology's most powerful tools: ...
Roche's AXELIOS 1 enters next generation DNA sequencing. Can it or rivals unseat Illumina's long-standing market dominance?
New research has shown that RNA-based testing can improve the detection and interpretation of clinically actionable genomic alterations that lead to MET exon 14 skipping in patients with lung ...
Shimadzu’s MultiNA II MCE-301 streamlines nucleic acid analysis with automated workflow, real-time data review and support ...
Citi Wealth's CIO is sounding the alarm on a threat most enterprise budgets are nowhere near prepared for, and she says AI ...
Analyst Tim Farrar called a potential launch-company purchase "likely foolish" but said AST needs to change its story. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results